A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years.
Clinical trial NCT00192179 · COMPLETED
Trial details
- NCT number
- NCT00192179
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2003-07-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.